Symbols / SCPX $0.01 +545.45% Scorpius Holdings, Inc.
SCPX Chart
About
Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. It is also involved in the provision of various process development services, including upstream and downstream development and optimization, and analytical method development solutions, as well as cell line development, testing, and characterization services. The company serves the biotechnology and biopharmaceutical industries. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in San Antonio, Texas.
Stock Fundamentals
Scroll to Statements| Market Cap | 434.11K | Enterprise Value | 12.30M | Income | -25.18M | Sales | 1.72M | Book/sh | -0.02 | Cash/sh | 0.01 |
| Dividend Yield | — | Payout | 0.00% | Employees | 90 | IPO | — | P/E | — | Forward P/E | -0.00 |
| PEG | — | P/S | 0.25 | P/B | -0.32 | P/C | — | EV/EBITDA | -0.56 | EV/Sales | 7.17 |
| Quick Ratio | 0.07 | Current Ratio | 0.10 | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | -4.18 | EPS next Y | -2.91 |
| EPS Growth | — | Revenue Growth | -75.10% | Earnings | 2024-04-26 | ROA | -47.94% | ROE | -3.03% | ROIC | — |
| Gross Margin | 0.00% | Oper. Margin | -20.57% | Profit Margin | 0.00% | Shs Outstand | 61.14M | Shs Float | 60.81M | Short Float | 2.25% |
| Short Ratio | 0.56 | Short Interest | — | 52W High | 0.15 | 52W Low | 0.00 | Beta | -4.99 | Avg Volume | 25.39K |
| Volume | 60.81K | Target Price | — | Recom | None | Prev Close | $0.00 | Price | $0.01 | Change | 545.45% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2023-05-01 | down | Brookline Capital | Buy → Hold | — |
| 2023-04-03 | down | Maxim Group | Buy → Hold | — |
| 2021-03-03 | init | Cantor Fitzgerald | — → Overweight | $22 |
- [8-K] Scorpius Holdings, Inc. Reports Material Event - Stock Titan ue, 07 Apr 2026 07
- Scorpius Holdings Faces Asset Sale Due to Defaults - TipRanks ue, 21 Oct 2025 07
- Scorpius Holdings, Inc. Announces Resignation of William Ostrander as Chief Financial Officer, Effective March 31, 2026 - marketscreener.com Wed, 08 Apr 2026 07
- Scorpius Holdings Announces Resignation of Chief Financial Officer - TipRanks Wed, 08 Apr 2026 07
- SCPX Stock Price and Chart — OTC:SCPX - TradingView Wed, 19 Jun 2024 23
- SCPX Stock Price, Quote & Chart | SCORPIUS HOLDINGS INC (NYSEARCA:SCPX) - ChartMill ue, 14 May 2024 19
- Scorpius Holdings Provides 2024 Year-End Business Update; Implem - GuruFocus Wed, 30 Apr 2025 07
- Scorpius Holdings Announces Reverse Stock Split - Yahoo Finance Wed, 17 Jul 2024 07
- Scorpius Holdings completes major asset foreclosure disposition - TipRanks hu, 29 Jan 2026 08
- Why Is Talis Biomedical (TLIS) Stock Down 52% Today? - InvestorPlace Wed, 07 Aug 2024 07
- Latest SCPX News - Tivic Health Enters GMP Manufacturing Valid... - Stock Titan hu, 07 Mar 2024 15
- NightHawk Biosciences Completes Name Change to Scorpius Holdings; Trading to Commence Under “SCPX” Effective at the Market Open Today - Yahoo Finance ue, 06 Feb 2024 08
- Scorpius Holdings Completes Major Private Placement Offering - TipRanks Wed, 14 May 2025 07
- Scorpius Holdings and Beyond Imagination Announce Trailblazing Partnership to Utilize Autonomous AI-Powered Humanoid Robots for American Biomanufacturing - Stock Titan Mon, 03 Jun 2024 07
- Jeffrey Wolf completed the acquisition of Elusys Therapeutics, Inc. from NightHawk Biosciences, Inc.. - marketscreener.com ue, 26 Dec 2023 08
Financials
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
6.24
-10.75%
|
6.99
+1789.60%
|
0.37
|
0.00
|
| Operating Revenue |
|
6.24
-10.75%
|
6.99
+1789.60%
|
0.37
|
0.00
|
| Cost Of Revenue |
|
3.20
+16.78%
|
2.74
+3266.75%
|
0.08
|
0.00
|
| Reconciled Cost Of Revenue |
|
3.20
+16.78%
|
2.74
+3266.75%
|
0.08
|
0.00
|
| Gross Profit |
|
3.05
-28.44%
|
4.26
+1373.91%
|
0.29
|
0.00
|
| Operating Expense |
|
35.90
-22.45%
|
46.29
+14.71%
|
40.35
+29.46%
|
31.17
|
| Research And Development |
|
14.33
-28.79%
|
20.12
-0.51%
|
20.22
+22.90%
|
16.46
|
| Selling General And Administration |
|
21.57
-17.57%
|
26.17
+30.00%
|
20.13
+19.62%
|
16.83
|
| General And Administrative Expense |
|
21.57
-17.57%
|
26.17
+30.00%
|
20.13
+19.62%
|
16.83
|
| Other Gand A |
|
21.57
-17.57%
|
26.17
+30.00%
|
20.13
+19.62%
|
16.83
|
| Other Operating Expenses |
|
—
|
—
|
-0.40
+80.96%
|
-2.11
|
| Total Expenses |
|
39.09
-20.26%
|
49.03
+21.25%
|
40.44
+29.72%
|
31.17
|
| Operating Income |
|
-32.85
+21.84%
|
-42.03
-4.91%
|
-40.07
-28.53%
|
-31.17
|
| Total Operating Income As Reported |
|
-33.60
+20.06%
|
-42.03
-4.50%
|
-40.22
-13.56%
|
-35.42
|
| EBITDA |
|
-26.22
+22.86%
|
-33.99
+11.16%
|
-38.26
-25.19%
|
-30.56
|
| Normalized EBITDA |
|
-25.38
+25.60%
|
-34.11
+6.32%
|
-36.41
-42.83%
|
-25.49
|
| Reconciled Depreciation |
|
7.15
-5.44%
|
7.57
+140.51%
|
3.15
+417.66%
|
0.61
|
| EBIT |
|
-33.37
+19.69%
|
-41.56
-0.36%
|
-41.41
-32.84%
|
-31.17
|
| Total Unusual Items |
|
-0.84
-781.42%
|
0.12
+106.66%
|
-1.85
+63.54%
|
-5.07
|
| Total Unusual Items Excluding Goodwill |
|
-0.84
-781.42%
|
0.12
+106.66%
|
-1.85
+63.54%
|
-5.07
|
| Special Income Charges |
|
-1.31
|
0.00
+100.00%
|
-0.16
+96.29%
|
-4.25
|
| Other Special Charges |
|
0.56
|
—
|
—
|
—
|
| Impairment Of Capital Assets |
|
1.94
|
0.00
|
0.00
-100.00%
|
1.45
|
| Restructuring And Mergern Acquisition |
|
-1.19
|
0.00
+100.00%
|
-3.34
-877.33%
|
0.43
|
| Write Off |
|
—
|
0.00
-100.00%
|
3.50
+47.93%
|
2.37
|
| Net Income |
|
-32.81
+27.44%
|
-45.22
-4.10%
|
-43.43
-23.85%
|
-35.07
|
| Pretax Income |
|
-34.33
+18.91%
|
-42.33
-1.79%
|
-41.59
-17.00%
|
-35.55
|
| Net Non Operating Interest Income Expense |
|
-0.93
-191.24%
|
-0.32
-139.72%
|
0.80
-1.30%
|
0.82
|
| Interest Expense Non Operating |
|
0.95
+22.70%
|
0.78
+325.64%
|
0.18
|
—
|
| Net Interest Income |
|
-0.93
-191.24%
|
-0.32
-139.72%
|
0.80
-1.30%
|
0.82
|
| Interest Expense |
|
0.95
+22.70%
|
0.78
+325.64%
|
0.18
|
—
|
| Interest Income Non Operating |
|
0.02
-95.14%
|
0.46
-53.69%
|
0.99
+21.09%
|
0.82
|
| Interest Income |
|
0.02
-95.14%
|
0.46
-53.69%
|
0.99
+21.09%
|
0.82
|
| Other Income Expense |
|
-0.55
-3095.45%
|
0.02
+100.78%
|
-2.33
+55.11%
|
-5.19
|
| Other Non Operating Income Expenses |
|
0.29
+379.16%
|
-0.10
+78.28%
|
-0.48
-291.55%
|
-0.12
|
| Gain On Sale Of Security |
|
0.47
+282.63%
|
0.12
+107.28%
|
-1.69
-106.20%
|
-0.82
|
| Tax Provision |
|
0.00
+100.00%
|
-0.57
-164.48%
|
-0.22
-47.93%
|
-0.15
|
| Tax Rate For Calcs |
|
0.00
-100.00%
|
0.00
+159.84%
|
0.00
+26.42%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
-100.00%
|
0.00
+117.30%
|
-0.01
+53.90%
|
-0.02
|
| Net Income Including Noncontrolling Interests |
|
-34.33
+26.70%
|
-46.83
-6.77%
|
-43.86
-23.90%
|
-35.40
|
| Net Income From Continuing Operation Net Minority Interest |
|
-32.81
+18.28%
|
-40.15
+1.96%
|
-40.95
-16.75%
|
-35.07
|
| Net Income From Continuing And Discontinued Operation |
|
-32.81
+27.44%
|
-45.22
-4.10%
|
-43.43
-23.85%
|
-35.07
|
| Net Income Continuous Operations |
|
-34.33
+17.80%
|
-41.76
-0.94%
|
-41.38
-16.88%
|
-35.40
|
| Net Income Discontinuous Operations |
|
0.00
+100.00%
|
-5.07
-103.88%
|
-2.49
|
—
|
| Minority Interests |
|
1.52
-5.95%
|
1.62
+278.02%
|
0.43
+29.80%
|
0.33
|
| Normalized Income |
|
-31.97
+20.61%
|
-40.27
-2.96%
|
-39.11
-30.26%
|
-30.02
|
| Net Income Common Stockholders |
|
-32.81
+27.44%
|
-45.22
-4.10%
|
-43.43
-23.85%
|
-35.07
|
| Diluted EPS |
|
-13.04
+96.25%
|
-347.50
-2.21%
|
-340.00
-20.57%
|
-282.00
|
| Basic EPS |
|
-13.04
+96.25%
|
-347.50
-2.21%
|
-340.00
-20.57%
|
-282.00
|
| Basic Average Shares |
|
2.52
+1833.40%
|
0.13
+1.63%
|
0.13
+2.78%
|
0.12
|
| Diluted Average Shares |
|
2.52
+1833.40%
|
0.13
+1.63%
|
0.13
+2.78%
|
0.12
|
| Diluted NI Availto Com Stockholders |
|
-32.81
+27.44%
|
-45.22
-4.10%
|
-43.43
-23.85%
|
-35.07
|
| Amortization |
|
—
|
—
|
1.03
|
0.00
|
| Amortization Of Intangibles Income Statement |
|
—
|
—
|
1.03
|
0.00
|
| Depreciation Amortization Depletion Income Statement |
|
—
|
—
|
1.03
|
0.00
|
| Depreciation And Amortization In Income Statement |
|
—
|
—
|
1.03
|
0.00
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
39.18
-23.24%
|
51.04
-51.11%
|
104.40
-13.69%
|
120.96
|
| Current Assets |
|
3.26
-31.50%
|
4.76
-90.49%
|
50.05
-49.61%
|
99.33
|
| Cash Cash Equivalents And Short Term Investments |
|
1.16
-51.36%
|
2.39
-93.87%
|
39.03
-59.50%
|
96.38
|
| Cash And Cash Equivalents |
|
1.03
+455.90%
|
0.18
-94.21%
|
3.19
-60.37%
|
8.05
|
| Other Short Term Investments |
|
0.14
-93.88%
|
2.21
-93.84%
|
35.84
-59.43%
|
88.32
|
| Receivables |
|
0.84
+9.84%
|
0.76
-52.47%
|
1.61
+2331.49%
|
0.07
|
| Accounts Receivable |
|
0.14
-61.76%
|
0.38
+360.61%
|
0.08
+23.33%
|
0.07
|
| Other Receivables |
|
0.70
+478.31%
|
0.12
-92.12%
|
1.52
|
—
|
| Taxes Receivable |
|
—
|
—
|
0.60
|
0.00
|
| Inventory |
|
0.20
-78.15%
|
0.91
|
0.00
|
—
|
| Prepaid Assets |
|
0.83
+118.82%
|
0.38
+6.01%
|
0.36
-85.22%
|
2.43
|
| Assets Held For Sale Current |
|
—
|
0.00
-100.00%
|
7.93
|
—
|
| Other Current Assets |
|
0.23
-27.78%
|
0.32
-72.04%
|
1.13
+146.18%
|
0.46
|
| Total Non Current Assets |
|
35.92
-22.39%
|
46.28
-14.84%
|
54.34
+151.24%
|
21.63
|
| Net PPE |
|
34.34
-22.13%
|
44.10
+5.93%
|
41.63
+843.64%
|
4.41
|
| Gross PPE |
|
37.34
-27.75%
|
51.68
+15.91%
|
44.59
+653.70%
|
5.92
|
| Accumulated Depreciation |
|
-3.00
+60.42%
|
-7.58
-156.67%
|
-2.95
-96.42%
|
-1.50
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
0.89
-21.54%
|
1.13
+42.36%
|
0.79
+424.16%
|
0.15
|
| Construction In Progress |
|
0.06
+511.02%
|
0.01
-99.54%
|
2.05
+563.18%
|
0.31
|
| Other Properties |
|
35.06
-26.52%
|
47.72
+21.56%
|
39.26
+622.61%
|
5.43
|
| Leases |
|
1.34
-52.76%
|
2.83
+13.71%
|
2.49
+10919.50%
|
0.02
|
| Goodwill And Other Intangible Assets |
|
—
|
—
|
11.97
+242.04%
|
3.50
|
| Goodwill |
|
—
|
—
|
3.30
|
0.00
|
| Other Intangible Assets |
|
—
|
—
|
8.67
+147.70%
|
3.50
|
| Non Current Accounts Receivable |
|
1.10
-36.05%
|
1.72
|
—
|
1.32
|
| Non Current Prepaid Assets |
|
0.27
+8.10%
|
0.25
-7.15%
|
0.27
+31.35%
|
0.21
|
| Other Non Current Assets |
|
0.20
+0.00%
|
0.20
-98.37%
|
12.44
+2.01%
|
12.19
|
| Total Liabilities Net Minority Interest |
|
37.50
+64.88%
|
22.74
-28.84%
|
31.96
+257.99%
|
8.93
|
| Current Liabilities |
|
24.29
+140.48%
|
10.10
-44.00%
|
18.04
+282.09%
|
4.72
|
| Payables And Accrued Expenses |
|
4.92
-17.72%
|
5.98
+6.03%
|
5.64
+95.58%
|
2.88
|
| Payables |
|
3.23
-22.21%
|
4.15
-2.47%
|
4.25
+280.55%
|
1.12
|
| Accounts Payable |
|
3.23
-21.48%
|
4.11
-2.46%
|
4.21
+356.63%
|
0.92
|
| Other Payable |
|
—
|
0.31
-26.47%
|
0.43
|
—
|
| Current Accrued Expenses |
|
1.69
-7.54%
|
1.83
+32.12%
|
1.39
-21.53%
|
1.77
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.30
-10.39%
|
0.33
-32.28%
|
0.49
+6.97%
|
0.46
|
| Total Tax Payable |
|
0.00
-100.00%
|
0.04
-3.00%
|
0.04
-79.49%
|
0.20
|
| Income Tax Payable |
|
—
|
—
|
1.09
|
0.00
|
| Current Debt And Capital Lease Obligation |
|
17.44
+1120.21%
|
1.43
+104.45%
|
0.70
+14.40%
|
0.61
|
| Current Debt |
|
16.02
|
—
|
—
|
—
|
| Other Current Borrowings |
|
16.02
|
—
|
—
|
—
|
| Current Capital Lease Obligation |
|
1.42
-0.62%
|
1.43
+104.45%
|
0.70
+14.40%
|
0.61
|
| Current Deferred Liabilities |
|
1.64
-30.67%
|
2.36
+48.78%
|
1.59
|
0.00
|
| Current Deferred Revenue |
|
1.64
-30.67%
|
2.36
+48.78%
|
1.59
|
0.00
|
| Other Current Liabilities |
|
—
|
0.31
-96.74%
|
9.62
+1153.93%
|
0.77
|
| Total Non Current Liabilities Net Minority Interest |
|
13.21
+4.49%
|
12.64
-9.19%
|
13.92
+230.95%
|
4.21
|
| Liabilities Heldfor Sale Non Current |
|
—
|
0.00
-100.00%
|
5.29
|
—
|
| Long Term Debt And Capital Lease Obligation |
|
11.11
-11.89%
|
12.61
+46.67%
|
8.60
+553.35%
|
1.32
|
| Long Term Capital Lease Obligation |
|
11.11
-11.89%
|
12.61
+46.67%
|
8.60
+553.35%
|
1.32
|
| Non Current Deferred Liabilities |
|
0.00
-100.00%
|
0.03
-7.69%
|
0.03
-87.05%
|
0.25
|
| Non Current Deferred Revenue |
|
0.00
-100.00%
|
0.03
-7.69%
|
0.03
-7.14%
|
0.04
|
| Non Current Deferred Taxes Liabilities |
|
—
|
—
|
0.00
-100.00%
|
0.22
|
| Other Non Current Liabilities |
|
—
|
—
|
5.29
+101.26%
|
2.63
|
| Stockholders Equity |
|
6.30
-79.94%
|
31.40
-57.53%
|
73.92
-34.64%
|
113.11
|
| Common Stock Equity |
|
6.30
-79.94%
|
31.40
-57.53%
|
73.92
-34.64%
|
113.11
|
| Capital Stock |
|
0.00
+3811.54%
|
0.00
-99.49%
|
0.01
+1.40%
|
0.01
|
| Common Stock |
|
0.00
+3811.54%
|
0.00
-99.49%
|
0.01
+1.40%
|
0.01
|
| Share Issued |
|
5.08
+3777.49%
|
0.13
+2.17%
|
0.13
+0.05%
|
0.13
|
| Ordinary Shares Number |
|
5.08
+3777.49%
|
0.13
+2.17%
|
0.13
+0.05%
|
0.13
|
| Additional Paid In Capital |
|
293.25
+2.64%
|
285.72
+0.95%
|
283.02
+1.48%
|
278.89
|
| Retained Earnings |
|
-287.18
-12.90%
|
-254.37
-21.62%
|
-209.15
-26.21%
|
-165.72
|
| Gains Losses Not Affecting Retained Earnings |
|
0.22
+358.52%
|
0.05
-5.87%
|
0.05
+176.43%
|
-0.07
|
| Minority Interest |
|
-4.62
-49.00%
|
-3.10
-108.74%
|
-1.49
-38.28%
|
-1.07
|
| Other Equity Adjustments |
|
0.22
+358.52%
|
0.05
-5.87%
|
0.05
+176.43%
|
-0.07
|
| Total Equity Gross Minority Interest |
|
1.68
-94.07%
|
28.29
-60.94%
|
72.44
-35.34%
|
112.03
|
| Total Capitalization |
|
6.30
-79.94%
|
31.40
-57.53%
|
73.92
-34.64%
|
113.11
|
| Working Capital |
|
-21.03
-293.84%
|
-5.34
-116.68%
|
32.02
-66.16%
|
94.61
|
| Invested Capital |
|
22.32
-28.93%
|
31.40
-57.53%
|
73.92
-34.64%
|
113.11
|
| Total Debt |
|
28.55
+103.31%
|
14.04
+51.01%
|
9.30
+382.50%
|
1.93
|
| Net Debt |
|
14.99
|
—
|
—
|
—
|
| Capital Lease Obligations |
|
12.53
-10.75%
|
14.04
+51.01%
|
9.30
+382.50%
|
1.93
|
| Net Tangible Assets |
|
6.30
-79.94%
|
31.40
-57.53%
|
73.92
-32.56%
|
109.61
|
| Tangible Book Value |
|
6.30
-79.94%
|
31.40
-57.53%
|
73.92
-32.56%
|
109.61
|
| Derivative Product Liabilities |
|
2.10
|
0.00
|
0.00
-100.00%
|
0.01
|
| Duefrom Related Parties Current |
|
0.00
-100.00%
|
0.27
|
0.00
|
—
|
| Duefrom Related Parties Non Current |
|
1.10
-36.05%
|
1.72
|
0.00
|
—
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-26.01
+17.52%
|
-31.53
-453.17%
|
-5.70
+85.05%
|
-38.13
|
| Cash Flow From Continuing Operating Activities |
|
-26.01
+17.52%
|
-31.53
-453.17%
|
-5.70
+85.05%
|
-38.13
|
| Net Income From Continuing Operations |
|
-34.33
+26.70%
|
-46.83
-6.77%
|
-43.86
-23.90%
|
-35.40
|
| Depreciation Amortization Depletion |
|
7.15
-5.44%
|
7.57
+140.51%
|
3.15
+417.66%
|
0.61
|
| Depreciation |
|
7.15
+10.50%
|
6.47
+206.11%
|
2.12
+248.05%
|
0.61
|
| Amortization Cash Flow |
|
0.00
-100.00%
|
1.09
+5.88%
|
1.03
|
0.00
|
| Depreciation And Amortization |
|
7.15
-5.44%
|
7.57
+140.51%
|
3.15
+417.66%
|
0.61
|
| Amortization Of Intangibles |
|
0.00
-100.00%
|
1.09
+5.88%
|
1.03
|
0.00
|
| Other Non Cash Items |
|
-0.77
-15.75%
|
-0.67
+80.04%
|
-3.34
-722.54%
|
0.54
|
| Stock Based Compensation |
|
1.03
-60.67%
|
2.63
-35.67%
|
4.09
-33.77%
|
6.17
|
| Asset Impairment Charge |
|
1.94
-68.47%
|
6.15
+75.74%
|
3.50
-8.34%
|
3.82
|
| Deferred Tax |
|
0.00
+100.00%
|
-0.57
+82.64%
|
-3.29
|
—
|
| Deferred Income Tax |
|
0.00
+100.00%
|
-0.57
+82.64%
|
-3.29
|
—
|
| Operating Gains Losses |
|
0.65
+144.57%
|
-1.47
-13216.25%
|
-0.01
+51.58%
|
-0.02
|
| Gain Loss On Investment Securities |
|
-0.47
|
—
|
-0.01
+51.58%
|
-0.02
|
| Unrealized Gain Loss On Investment Securities |
|
-0.00
+99.19%
|
-0.12
-107.23%
|
1.70
+101.94%
|
0.84
|
| Gain Loss On Sale Of PPE |
|
0.56
|
0.00
|
—
|
—
|
| Change In Working Capital |
|
-1.69
-194.68%
|
1.78
-94.49%
|
32.36
+320.49%
|
-14.68
|
| Change In Receivables |
|
0.23
-87.28%
|
1.83
-92.60%
|
24.75
+2148.26%
|
-1.21
|
| Changes In Account Receivables |
|
0.23
+179.30%
|
-0.29
-1739.41%
|
-0.02
-114.50%
|
0.11
|
| Change In Inventory |
|
0.71
+178.15%
|
-0.91
-115.56%
|
5.84
|
0.00
|
| Change In Prepaid Assets |
|
-0.78
-128.26%
|
2.77
+47083.28%
|
-0.01
+99.48%
|
-1.14
|
| Change In Payables And Accrued Expense |
|
-0.92
+54.65%
|
-2.04
-1277.13%
|
0.17
-78.41%
|
0.80
|
| Change In Accrued Expense |
|
-0.04
+97.81%
|
-1.92
+38.53%
|
-3.13
-436.50%
|
0.93
|
| Change In Payable |
|
-0.88
-654.80%
|
-0.12
-103.54%
|
3.30
+2699.18%
|
-0.13
|
| Change In Account Payable |
|
-0.88
-654.80%
|
-0.12
-103.54%
|
3.30
+2699.18%
|
-0.13
|
| Change In Other Working Capital |
|
-0.92
-219.74%
|
0.77
-51.30%
|
1.58
+266.28%
|
-0.95
|
| Change In Other Current Assets |
|
0.00
+100.00%
|
-0.65
-957.91%
|
0.08
+100.62%
|
-12.19
|
| Change In Other Current Liabilities |
|
—
|
0.00
+100.00%
|
-0.05
-409.67%
|
0.02
|
| Investing Cash Flow |
|
1.21
-96.23%
|
32.24
+193.28%
|
10.99
+12.50%
|
9.77
|
| Cash Flow From Continuing Investing Activities |
|
1.21
-96.23%
|
32.24
+193.28%
|
10.99
+12.50%
|
9.77
|
| Net PPE Purchase And Sale |
|
-0.86
+51.37%
|
-1.76
+91.06%
|
-19.73
-935.85%
|
-1.90
|
| Purchase Of PPE |
|
-0.88
+55.92%
|
-1.99
+90.13%
|
-20.12
-956.22%
|
-1.90
|
| Sale Of PPE |
|
0.02
-92.34%
|
0.22
-43.11%
|
0.39
|
0.00
|
| Capital Expenditure |
|
-0.88
+55.92%
|
-1.99
+90.13%
|
-20.12
-956.22%
|
-1.90
|
| Net Investment Purchase And Sale |
|
2.07
-93.90%
|
34.00
-33.05%
|
50.79
+335.00%
|
11.67
|
| Purchase Of Investment |
|
-0.94
-93.51%
|
-0.48
+80.32%
|
-2.46
+96.33%
|
-66.96
|
| Sale Of Investment |
|
3.01
-91.28%
|
34.48
-35.23%
|
53.24
-32.29%
|
78.64
|
| Net Business Purchase And Sale |
|
—
|
0.00
+100.00%
|
-20.06
|
0.00
|
| Purchase Of Business |
|
—
|
0.00
+100.00%
|
-22.78
|
0.00
|
| Gain Loss On Sale Of Business |
|
0.00
+100.00%
|
-1.47
|
0.00
|
—
|
| Financing Cash Flow |
|
25.64
+386.37%
|
-8.95
-82.44%
|
-4.91
-119.25%
|
25.49
|
| Cash Flow From Continuing Financing Activities |
|
25.64
+386.37%
|
-8.95
-82.44%
|
-4.91
-119.25%
|
25.49
|
| Net Issuance Payments Of Debt |
|
2.33
+190.18%
|
-2.58
-1015.38%
|
-0.23
-26.57%
|
-0.18
|
| Issuance Of Debt |
|
3.23
|
0.00
|
—
|
0.00
|
| Repayment Of Debt |
|
-0.90
+65.21%
|
-2.58
-1015.38%
|
-0.23
-26.57%
|
-0.18
|
| Long Term Debt Issuance |
|
0.97
|
0.00
|
—
|
0.00
|
| Long Term Debt Payments |
|
-0.90
+65.21%
|
-2.58
-1015.38%
|
-0.23
-26.57%
|
-0.18
|
| Net Long Term Debt Issuance |
|
0.08
+102.95%
|
-2.58
-1015.38%
|
-0.23
-26.57%
|
-0.18
|
| Short Term Debt Issuance |
|
2.25
|
0.00
|
—
|
—
|
| Net Short Term Debt Issuance |
|
2.25
|
0.00
|
—
|
—
|
| Net Common Stock Issuance |
|
25.34
+38512.59%
|
0.07
+9.94%
|
0.06
-99.77%
|
26.30
|
| Proceeds From Stock Option Exercised |
|
0.19
|
0.00
|
0.00
-100.00%
|
0.03
|
| Net Other Financing Charges |
|
-2.22
+65.43%
|
-6.43
-35.88%
|
-4.74
-619.40%
|
-0.66
|
| Changes In Cash |
|
0.84
+110.23%
|
-8.25
-2246.26%
|
0.38
+113.40%
|
-2.87
|
| Effect Of Exchange Rate Changes |
|
-0.00
+47.72%
|
-0.00
+57.09%
|
-0.00
+62.71%
|
-0.01
|
| Beginning Cash Position |
|
0.18
-97.81%
|
8.43
+4.73%
|
8.05
-26.33%
|
10.93
|
| End Cash Position |
|
1.03
+455.90%
|
0.18
-97.81%
|
8.43
+4.73%
|
8.05
|
| Free Cash Flow |
|
-26.88
+19.80%
|
-33.52
-29.82%
|
-25.82
+35.51%
|
-40.03
|
| Common Stock Issuance |
|
25.34
+38512.59%
|
0.07
+9.94%
|
0.06
-99.77%
|
26.30
|
| Issuance Of Capital Stock |
|
25.34
+38512.59%
|
0.07
+9.94%
|
0.06
-99.77%
|
26.30
|
| Sale Of Business |
|
—
|
0.00
-100.00%
|
2.72
|
0.00
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|